Literature DB >> 9303385

Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine.

M Iten1, H Mett, A Evans, J C Enyaru, R Brun, R Kaminsky.   

Abstract

Ornithine decarboxylase (ODC), the target enzyme of D,L-alpha-difluoromethylornithine (DFMO), was investigated in four DFMO-tolerant Trypanosoma brucei rhodesiense isolates from East Africa and two DFMO-susceptible T. b. gambiense isolates from West Africa. Neither drug uptake nor inhibition of ODC activity by DFMO in cellular extracts differed in the two trypanosome subspecies. However, the specific ODC activity of the cellular extracts was three times as high in T. b. rhodesiense isolates as in T. b. gambiense isolates. Furthermore, a significant difference in the turnover rate of ODC was observed. The time required to induce a 50% reduction of T. b. rhodesiense ODC activity under cycloheximide pressure (tentative half-life) was about 4.3 h, whereas that required for T. b. gambiense ODC was longer than 18 h. We concluded that the higher specific ODC activity and faster enzyme turnover contributed to a substantial degree to the DFMO tolerance observed in the East African T. b. rhodesiense isolates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303385      PMCID: PMC164036          DOI: 10.1128/AAC.41.9.1922

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Cloning of a trypanosomatid gene coding for an ornithine decarboxylase that is metabolically unstable even though it lacks the C-terminal degradation domain.

Authors:  F Svensson; C Ceriani; E L Wallström; I Kockum; I D Algranati; O Heby; L Persson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Uptake of alpha-difluoromethylornithine by Trypanosoma brucei brucei.

Authors:  A J Bitonti; C J Bacchi; P P McCann; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1986-01-15       Impact factor: 5.858

3.  Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.

Authors:  S Rogers; R Wells; M Rechsteiner
Journal:  Science       Date:  1986-10-17       Impact factor: 47.728

Review 4.  Polyamines.

Authors:  C W Tabor; H Tabor
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

5.  Epidemiological studies on the animal reservoir of gambiense sleeping sickness. Part I. Review of literature and description of the study areas.

Authors:  D Mehlitz; U Brinkmann; L Haller
Journal:  Tropenmed Parasitol       Date:  1981-09

6.  Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose.

Authors:  S M Lanham; D G Godfrey
Journal:  Exp Parasitol       Date:  1970-12       Impact factor: 2.011

7.  In vivo effects of alpha-DL-difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei.

Authors:  C J Bacchi; J Garofalo; D Mockenhaupt; P P McCann; K A Diekema; A E Pegg; H C Nathan; E A Mullaney; L Chunosoff; A Sjoerdsma; S H Hutner
Journal:  Mol Biochem Parasitol       Date:  1983-03       Impact factor: 1.759

Review 8.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

9.  Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial.

Authors:  S Van Nieuwenhove; P J Schechter; J Declercq; G Boné; J Burke; A Sjoerdsma
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

10.  Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense.

Authors:  T Baltz; D Baltz; C Giroud; J Crockett
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

View more
  28 in total

Review 1.  Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future.

Authors:  Wim G J Hol
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-04-16       Impact factor: 1.056

2.  Synthesis and evaluation of analogs of 5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity.

Authors:  Anthony J Brockway; Oleg A Volkov; Casey C Cosner; Karen S MacMillan; Stephen A Wring; Thomas E Richardson; Michael Peel; Margaret A Phillips; Jef K De Brabander
Journal:  Bioorg Med Chem       Date:  2017-08-03       Impact factor: 3.641

3.  Species-Selective Pyrimidineamine Inhibitors of Trypanosoma brucei S-Adenosylmethionine Decarboxylase.

Authors:  Oleg A Volkov; Anthony J Brockway; Stephen A Wring; Michael Peel; Zhe Chen; Margaret A Phillips; Jef K De Brabander
Journal:  J Med Chem       Date:  2018-01-05       Impact factor: 7.446

4.  Target repurposing for neglected diseases.

Authors:  Michael P Pollastri; Robert K Campbell
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

Review 5.  Human African trypanosomiasis in endemic populations and travellers.

Authors:  J A Blum; A L Neumayr; C F Hatz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-07       Impact factor: 3.267

6.  Investigation of the antitrypanosomal activity of Buchholzia coriacea seed extract against a field strain of Trypanosoma congolense.

Authors:  N E Nweze; B M Anene; I U Asuzu
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-07-03

7.  In vitro and in vivo activities of trybizine hydrochloride against various pathogenic trypanosome species.

Authors:  R Kaminsky; R Brun
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

8.  The development of drugs for treatment of sleeping sickness: a historical review.

Authors:  Dietmar Steverding
Journal:  Parasit Vectors       Date:  2010-03-10       Impact factor: 3.876

Review 9.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

10.  Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes.

Authors:  Nicola Baker; Lucy Glover; Jane C Munday; David Aguinaga Andrés; Michael P Barrett; Harry P de Koning; David Horn
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.